Application no. and date | 19710488.8 (espacenet) (Federated) (European Patent Register), 20190208 | Patent/reg. no. and date | DK/EP 3749353, 20250730 | Publication date | 20201216 | Priority no. and date | US 201862628714 P, 20180209 | EP pub. no. and date |
EP 3749353 20201216 | Effective date | | Applicant/owner | Chugai Seiyaku Kabushiki Kaisha, 5-1, Ukima 5-chome
Kita-ku Tokyo 115-8543, JP, Galderma Holding SA, Zählerweg 10 6300 Zug , CH | Applicant ref. no. | V494047DK00 | Inventor | KERROUCHE, Nabil, 1, chemin des Moulins, Le Rouret
06650 Le Rouret, FR, HIROKAWA, Keiko, c/o Chugai Seiyaku Kabushiki Kaisha, 1-1 Nihonbashi-Muromachi 2-Chome, Chuo-ku
Tokyo, Tokyo 103-8324, JP, MIHARA, Ryosuke, c/o Chugai Seiyaku Kabushiki Kaisha, 1-1 Nihonbashi-Muromachi 2-Chome, Chuo-ku
Tokyo, Tokyo 103-8324, JP | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 39/00 (2006.01) , A61P 17/04 (2006.01) , C07K 16/28 (2006.01) | Title | NEMOLIZUMAB TIL BEHANDLING AF ATOPISK DERMATITIS MED MODERAT TIL SVÆR EXCORIATION | Int. application no. | IB2019051051 | Int. publication no. | WO2019155427 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|